Companies House 2024-07-01 2025-06-30 false 11424840 2024-07-01 2025-06-30 11424840 2025-06-30 11424840 2024-06-30 11424840 2024-07-01 2025-06-30 11424840 uk-bus:Director1 2024-07-01 2025-06-30 11424840 uk-bus:Director2 2024-07-01 2025-06-30 11424840 2024-07-01 2025-06-30 11424840 uk-bus:Micro-entities 2024-07-01 2025-06-30 11424840 uk-bus:FullAccounts 2024-07-01 2025-06-30 11424840 uk-bus:AuditExempt-NoAccountantsReport 2024-07-01 2025-06-30 11424840 uk-core:WithinOneYear 2025-06-30 11424840 uk-core:AfterOneYear 2025-06-30 11424840 2023-07-01 2024-06-30 11424840 uk-core:WithinOneYear 2024-06-30 11424840 uk-core:AfterOneYear 2024-06-30 iso4217:GBP xbrli:pure

# PR SAT LTD

Company number: 11424840

## Micro-entity accounts

Balance sheet date: 30 June 2025

Currency: GBP

Balance sheet item | Current year 2025 | Previous year 2024
--- | --- | ---
Called up share capital not paid | 10,000 | 10,000
Total fixed assets | 10,000 | 10,000
Total current assets | 5,000 | 5,000
Prepayments and accrued income | 0 | 0
Creditors due within one year | 0 | 0
Net current assets / liabilities | 5,000 | 5,000
Total assets less current liabilities | 25,000 | 25,000
Creditors due after one year | 0 | 0
Total net assets / liabilities | 25,000 | 25,000
Capital and reserves | 25,000 | 25,000
Average number of employees | 2 | 2

## Statements

For the year ending 30 June 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.

The accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

## Approval

Approved by the Board on 12 May 2026

And signed on their behalf by:
NASSOURI, Arash, Dr, Director